A novel proteomics-based clinical diagnostics technology identifies heterogeneity in activated signaling pathways in gastric cancers.

by Jeeyun Lee, Sung Kim, Phillip Kim, Xinjun Liu, Tani Lee, Kyoung-Mee Kim, In-Gu Do, Joon Oh Park, Se Hoon Park, Jiryeon Jang, Nicholas Hoe, Gulia Harvie, Anne Kuller, Anjali Jain, Gary Meyer, Glen Leesman, Young Suk Park, Min Gew Choi, Tae Sung Sohn, Jae Moon Bae, Ho Yeong Lim, Sharat Singh, Won Ki Kang
Published 2013-01-01